Do analysts prefer CGTX or OPTH?

Cognition Therapeutics presently has a consensus price target of $3.33, suggesting a potential upside of 280.13%. Given Cognition Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Cognition Therapeutics is more favorable than Optimi Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cognition Therapeutics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is CGTX or OPTH more profitable?

Optimi Health's return on equity of 0.00% beat Cognition Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Cognition Therapeutics N/A -50.17% -40.22% Optimi Health N/A N/A N/A

Does the media refer more to CGTX or OPTH?

In the previous week, Cognition Therapeutics and Cognition Therapeutics both had 3 articles in the media. Cognition Therapeutics' average media sentiment score of 0.80 beat Optimi Health's score of 0.60 indicating that Cognition Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cognition Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Optimi Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ICCC or OPTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmuCell 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher earnings and valuation, ICCC or OPTH?

ImmuCell has higher revenue and earnings than Optimi Health. Optimi Health is trading at a lower price-to-earnings ratio than ImmuCell, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ImmuCell $27.64M 3.22 -$1.04M $0.08 122.50 Optimi Health $310K 74.31 -$1.12M -$0.76 N/A

Do analysts recommend NMRA or OPTH?

Neumora Therapeutics currently has a consensus price target of $6.57, indicating a potential upside of 1,281.42%. Given Neumora Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Neumora Therapeutics is more favorable than Optimi Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neumora Therapeutics 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is NMRA or OPTH more profitable?

Optimi Health's return on equity of 0.00% beat Neumora Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Neumora Therapeutics N/A -242.28% -131.32% Optimi Health N/A N/A N/A

Does the media refer more to NMRA or OPTH?

In the previous week, Neumora Therapeutics and Neumora Therapeutics both had 3 articles in the media. Neumora Therapeutics' average media sentiment score of 1.37 beat Optimi Health's score of 0.60 indicating that Neumora Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neumora Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Optimi Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate OPTH or NTRB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to OPTH or NTRB?

In the previous week, Optimi Health and Optimi Health both had 3 articles in the media. Nutriband's average media sentiment score of 0.61 beat Optimi Health's score of 0.60 indicating that Nutriband is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Optimi Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nutriband 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate MNOV or OPTH?

MediciNova presently has a consensus price target of $7.75, suggesting a potential upside of 409.87%. Given MediciNova's stronger consensus rating and higher possible upside, equities analysts plainly believe MediciNova is more favorable than Optimi Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediciNova 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to MNOV or OPTH?

In the previous week, MediciNova had 2 more articles in the media than Optimi Health. MarketBeat recorded 5 mentions for MediciNova and 3 mentions for Optimi Health. MediciNova's average media sentiment score of 0.76 beat Optimi Health's score of 0.60 indicating that MediciNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MediciNova 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Optimi Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Optimi Health (OPTH) Competitors

$4.02 0.00 (0.00%)

As of 10/9/2026 03:59 PM Eastern

Compare

OPTH vs. CGTX, ICCC, NMRA, NTRB, and MNOV

Should you buy Optimi Health stock or one of its competitors? Optimi Health's main competitors and comparable companies include Cognition Therapeutics (CGTX), ImmuCell (ICCC), Neumora Therapeutics (NMRA), Nutriband (NTRB), and MediciNova (MNOV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Optimi Health compare to Cognition Therapeutics?

Cognition Therapeutics (NASDAQ:CGTX) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

In the previous week, Cognition Therapeutics and Cognition Therapeutics both had 3 articles in the media. Cognition Therapeutics' average media sentiment score of 0.80 beat Optimi Health's score of 0.60 indicating that Cognition Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cognition Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Optimi Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cognition Therapeutics presently has a consensus price target of $3.33, suggesting a potential upside of 280.13%. Given Cognition Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Cognition Therapeutics is more favorable than Optimi Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cognition Therapeutics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Optimi Health has higher revenue and earnings than Cognition Therapeutics. Optimi Health is trading at a lower price-to-earnings ratio than Cognition Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cognition Therapeutics	N/A	N/A	-$23.49M	-$0.17	N/A
Optimi Health	$310K	74.31	-$1.12M	-$0.76	N/A

Optimi Health's return on equity of 0.00% beat Cognition Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cognition Therapeutics	N/A	-50.17%	-40.22%
Optimi Health	N/A	N/A	N/A

43.4% of Cognition Therapeutics shares are held by institutional investors. 11.1% of Cognition Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Cognition Therapeutics beats Optimi Health on 8 of the 12 factors compared between the two stocks.

How does Optimi Health compare to ImmuCell?

ImmuCell (NASDAQ:ICCC) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings, profitability and media sentiment.

ImmuCell has higher revenue and earnings than Optimi Health. Optimi Health is trading at a lower price-to-earnings ratio than ImmuCell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ImmuCell	$27.64M	3.22	-$1.04M	$0.08	122.50
Optimi Health	$310K	74.31	-$1.12M	-$0.76	N/A

ImmuCell has a net margin of 2.57% compared to Optimi Health's net margin of 0.00%. ImmuCell's return on equity of 2.69% beat Optimi Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ImmuCell	2.57%	2.69%	1.76%
Optimi Health	N/A	N/A	N/A

13.5% of ImmuCell shares are held by institutional investors. 5.7% of ImmuCell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ImmuCell	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Optimi Health had 2 more articles in the media than ImmuCell. MarketBeat recorded 3 mentions for Optimi Health and 1 mentions for ImmuCell. ImmuCell's average media sentiment score of 1.82 beat Optimi Health's score of 0.60 indicating that ImmuCell is being referred to more favorably in the media.

Company	Overall Sentiment
ImmuCell	Very Positive
Optimi Health	Positive

Summary

ImmuCell beats Optimi Health on 11 of the 13 factors compared between the two stocks.

How does Optimi Health compare to Neumora Therapeutics?

Neumora Therapeutics (NASDAQ:NMRA) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

47.7% of Neumora Therapeutics shares are owned by institutional investors. 26.9% of Neumora Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Neumora Therapeutics currently has a consensus price target of $6.57, indicating a potential upside of 1,281.42%. Given Neumora Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Neumora Therapeutics is more favorable than Optimi Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neumora Therapeutics	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Neumora Therapeutics and Neumora Therapeutics both had 3 articles in the media. Neumora Therapeutics' average media sentiment score of 1.37 beat Optimi Health's score of 0.60 indicating that Neumora Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neumora Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Optimi Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Optimi Health has higher revenue and earnings than Neumora Therapeutics. Optimi Health is trading at a lower price-to-earnings ratio than Neumora Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neumora Therapeutics	N/A	N/A	-$236.93M	-$1.23	N/A
Optimi Health	$310K	74.31	-$1.12M	-$0.76	N/A

Optimi Health's return on equity of 0.00% beat Neumora Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neumora Therapeutics	N/A	-242.28%	-131.32%
Optimi Health	N/A	N/A	N/A

Summary

Neumora Therapeutics beats Optimi Health on 8 of the 13 factors compared between the two stocks.

How does Optimi Health compare to Nutriband?

Optimi Health (NASDAQ:OPTH) and Nutriband (NASDAQ:NTRB) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

In the previous week, Optimi Health and Optimi Health both had 3 articles in the media. Nutriband's average media sentiment score of 0.61 beat Optimi Health's score of 0.60 indicating that Nutriband is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Optimi Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nutriband	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

19.7% of Nutriband shares are owned by institutional investors. 52.2% of Nutriband shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Optimi Health has higher earnings, but lower revenue than Nutriband. Nutriband is trading at a lower price-to-earnings ratio than Optimi Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Optimi Health	$310K	74.31	-$1.12M	-$0.76	N/A
Nutriband	$2.04M	39.64	-$8.23M	-$0.53	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Optimi Health has a net margin of 0.00% compared to Nutriband's net margin of -430.35%. Optimi Health's return on equity of 0.00% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Optimi Health	N/A	N/A	N/A
Nutriband	-430.35%	-109.07%	-95.54%

Summary

Optimi Health beats Nutriband on 6 of the 11 factors compared between the two stocks.

How does Optimi Health compare to MediciNova?

MediciNova (NASDAQ:MNOV) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Optimi Health has lower revenue, but higher earnings than MediciNova. MediciNova is trading at a lower price-to-earnings ratio than Optimi Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediciNova	$410K	182.47	-$12M	-$0.21	N/A
Optimi Health	$310K	74.31	-$1.12M	-$0.76	N/A

In the previous week, MediciNova had 2 more articles in the media than Optimi Health. MarketBeat recorded 5 mentions for MediciNova and 3 mentions for Optimi Health. MediciNova's average media sentiment score of 0.76 beat Optimi Health's score of 0.60 indicating that MediciNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MediciNova	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Optimi Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MediciNova presently has a consensus price target of $7.75, suggesting a potential upside of 409.87%. Given MediciNova's stronger consensus rating and higher possible upside, equities analysts plainly believe MediciNova is more favorable than Optimi Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediciNova	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

9.9% of MediciNova shares are held by institutional investors. 14.0% of MediciNova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Optimi Health has a net margin of 0.00% compared to MediciNova's net margin of -1,168.70%. Optimi Health's return on equity of 0.00% beat MediciNova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediciNova	-1,168.70%	-26.51%	-24.39%
Optimi Health	N/A	N/A	N/A

Summary

MediciNova beats Optimi Health on 11 of the 16 factors compared between the two stocks.

Get Optimi Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OPTH vs. The Competition

Export

Metric	Optimi Health	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$23.04M	$12.39B	$7.25B	$13.28B
Dividend Yield	N/A	2.63%	2.52%	22.58%
P/E Ratio	-5.29	800.13	275.59	26.13
Price / Sales	74.31	754.43	586.27	86.30
Price / Cash	N/A	15.28	27.30	36.12
Price / Book	N/A	9.15	10.82	6.16
Net Income	-$1.12M	$2.84B	$3.50B	$381.12M
7 Day Performance	-6.51%	-0.88%	-1.19%	-1.43%
1 Month Performance	-9.05%	-3.66%	-4.00%	-3.36%
1 Year Performance	N/A	-3.95%	7.13%	1.49%

Optimi Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OPTH Optimi Health	0.3319 of 5 stars	$4.02 flat	N/A	N/A	$23.04M	$310K	N/A	9
CGTX Cognition Therapeutics	2.197 of 5 stars	$0.90 -4.4%	$3.33 +272.4%	-52.1%	$89.07M	N/A	N/A	14	News Coverage
ICCC ImmuCell	0.9053 of 5 stars	$9.75 +0.6%	N/A	+44.1%	$88.01M	$27.64M	121.89	73
NMRA Neumora Therapeutics	4.2374 of 5 stars	$0.48 +2.5%	$6.57 +1,269.6%	-74.8%	$87.99M	N/A	N/A	63	News Coverage Positive News Analyst Downgrade Gap Down
NTRB Nutriband	1.1485 of 5 stars	$6.05 -10.5%	N/A	-11.5%	$82.11M	$2.04M	N/A	3

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OPTH) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Optimi Health (OPTH) Competitors

OPTH vs. CGTX, ICCC, NMRA, NTRB, and MNOV

How does Optimi Health compare to Cognition Therapeutics?

Summary

How does Optimi Health compare to ImmuCell?

Summary

How does Optimi Health compare to Neumora Therapeutics?

Summary

How does Optimi Health compare to Nutriband?

Summary

How does Optimi Health compare to MediciNova?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPTH vs. The Competition

Optimi Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Optimi Health (OPTH) Competitors

OPTH vs. CGTX, ICCC, NMRA, NTRB, and MNOV

How does Optimi Health compare to Cognition Therapeutics?

Does the media refer more to CGTX or OPTH?

Do analysts prefer CGTX or OPTH?

Which has preferable earnings & valuation, CGTX or OPTH?

Is CGTX or OPTH more profitable?

Do insiders and institutionals believe in CGTX or OPTH?

Summary

How does Optimi Health compare to ImmuCell?

Which has higher earnings and valuation, ICCC or OPTH?

Is ICCC or OPTH more profitable?

Do institutionals and insiders believe in ICCC or OPTH?

Do analysts prefer ICCC or OPTH?

Does the media favor ICCC or OPTH?

Summary

How does Optimi Health compare to Neumora Therapeutics?

Do insiders and institutionals have more ownership in NMRA or OPTH?

Do analysts recommend NMRA or OPTH?

Does the media refer more to NMRA or OPTH?

Which has better valuation and earnings, NMRA or OPTH?

Is NMRA or OPTH more profitable?

Summary

How does Optimi Health compare to Nutriband?

Does the media refer more to OPTH or NTRB?

Do institutionals and insiders believe in OPTH or NTRB?

Which has better earnings and valuation, OPTH or NTRB?

Do analysts rate OPTH or NTRB?

Is OPTH or NTRB more profitable?

Summary

How does Optimi Health compare to MediciNova?

Which has higher valuation & earnings, MNOV or OPTH?

Does the media refer more to MNOV or OPTH?

Do analysts rate MNOV or OPTH?

Do insiders & institutionals have more ownership in MNOV or OPTH?

Is MNOV or OPTH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPTH vs. The Competition

Optimi Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools